Label: SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL- salicylic acid spray

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 21, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

  • Active Ingredient

    Salicylic Acid, 2%

    Purpose

    Antidandruff

  • Use:

    Controls scalp itching and flaking due to dandruff

  • Warnings

    For external use only

    When using this product

    avoid contact with eyes. If contact, rinse eyes thoroughly with water.

    Stop use and consult a doctor if

    condition worsens or does not improve after regular use of this product as directed.

    Keep out of reach of children.

    If swallowed, get medical help or call a Poison Control Center at once.

  • Directions

    Spray to apply to the affected area 1-4 times daily, or as directed by a doctor

  • Inactive Ingredients

    Water, Glycerin, Sodium Hydroxide, PEG-40 Hydrogenate Castor Oil, PEG-12 Dimethicone, Propylene Glycol, Hydrolyzed Collagen, Diazolidinyl Urea, Disodium EDT, Methylparaben, Propylparaben, Ethylhexylglycerin, PEG-12 Alyl Ether, PEG-12, Butylene Glycol, Phenoxyethanol, Fragrance

  • Package Labeling:

    image description

  • INGREDIENTS AND APPEARANCE
    SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL 
    salicylic acid spray
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:12022-032
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    PEG-12 DIMETHICONE (300 CST) (UNII: ZEL54N6W95)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4)  
    EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    POLYETHYLENE GLYCOL 600 (UNII: NL4J9F21N9)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:12022-032-00355 mL in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM03201/01/2020
    Labeler - J. Strickland and Co. (007023112)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!